Transitional cell carcinoma (TCC), also called urothelial carcinoma, is a malignant tumour of the urinary tract lining. It is rare in cats, but it is the most frequently diagnosed malignant tumour of the lower urinary tract, and it enters the differential list for an older cat with lower urinary tract signs that persist or keep returning.
Key facts
Transitional cell carcinoma at a glance- Species and system: cat, lower urinary tract (usually the bladder).
- Frequency: neoplasia of the ureters, bladder and urethra is rare in cats (MSD). TCC is the most common malignant tumour in this region, and the second most common urinary neoplasm after renal lymphoma.
- Signalment: older cats; median age 15 years (range 5 to 21) in 118 cases.
- Classic presentation: hematuria, pollakiuria and stranguria for weeks, often in a cat previously treated for urinary tract disease.
- Treatment: partial cystectomy and NSAIDs offer the best outcomes; it is palliative, not curative.
- Zoonotic or reportable: no.
What's inside
11 sections in the full guide- Key facts
- How the NAVLE tests this
- Cause and pathophysiology
- Clinical signs
- Diagnosis
- Differential diagnoses
- Treatment and management
- Prognosis
- Quick review
- Test yourself
- References
The full guide also has 5 tables, 1 figure, 3 self-test questions and 5 references, available to NAVLE members.
Read the full study guide
The full guide is part of every NAVLE plan, with diagnosis and treatment tables, figures, a quick review and self-test questions. Start a free trial to try the question bank, or log in if you are already a member.